Pancreatic cancer: Advances and challenges

CJ Halbrook, CA Lyssiotis, MP di Magliano, A Maitra - Cell, 2023 - cell.com
Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers. Significant
efforts have largely defined major genetic factors driving PDAC pathogenesis and …

Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions

Z Megyesfalvi, CM Gay, H Popper… - CA: a cancer journal …, 2023 - Wiley Online Library
Small cell lung cancer (SCLC) is characterized by rapid growth and high metastatic capacity.
It has strong epidemiologic and biologic links to tobacco carcinogens. Although the majority …

Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer

LA Rojas, Z Sethna, KC Soares, C Olcese, N Pang… - Nature, 2023 - nature.com
Pancreatic ductal adenocarcinoma (PDAC) is lethal in 88% of patients, yet harbours
mutation-derived T cell neoantigens that are suitable for vaccines,. Here in a phase I trial of …

Pembrolizumab plus chemotherapy in advanced endometrial cancer

RN Eskander, MW Sill, L Beffa, RG Moore… - … England Journal of …, 2023 - Mass Medical Soc
Background Standard first-line chemotherapy for endometrial cancer is paclitaxel plus
carboplatin. The benefit of adding pembrolizumab to chemotherapy remains unclear …

Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial

N Agarwal, AA Azad, J Carles, AP Fay, N Matsubara… - The Lancet, 2023 - thelancet.com
Background Co-inhibition of poly (ADP-ribose) polymerase (PARP) and androgen receptor
activity might result in antitumour efficacy irrespective of alterations in DNA damage repair …

Esophageal and esophagogastric junction cancers, version 2.2023, NCCN clinical practice guidelines in oncology

JA Ajani, TA D'Amico, DJ Bentrem, D Cooke… - Journal of the National …, 2023 - jnccn.org
Cancers originating in the esophagus or esophagogastric junction constitute a major global
health problem. Esophageal cancers are histologically classified as squamous cell …

Screening for lung cancer: 2023 guideline update from the American Cancer Society

A Wolf, KC Oeffinger, TYC Shih… - CA: A Cancer …, 2023 - digitalscholar.lsuhsc.edu
Lung cancer is the leading cause of mortality and person-years of life lost from cancer
among US men and women. Early detection has been shown to be associated with reduced …

Molecular mechanisms of tumor resistance to radiotherapy

Y Wu, Y Song, R Wang, T Wang - Molecular Cancer, 2023 - Springer
Background Cancer is the most prevalent cause of death globally, and radiotherapy is
considered the standard of care for most solid tumors, including lung, breast, esophageal …

NCCN guidelines® Insights: biliary tract cancers, version 2.2023: featured updates to the NCCN guidelines

AB Benson, MI D'Angelica, T Abrams… - Journal of the National …, 2023 - jnccn.org
In 2023, the NCCN Guidelines for Hepatobiliary Cancers were divided into 2 separate
guidelines: Hepatocellular Carcinoma and Biliary Tract Cancers. The NCCN Guidelines for …

Early detection of prostate cancer: AUA/SUO guideline part I: prostate cancer screening

JT Wei, D Barocas, S Carlsson, F Coakley… - Journal of …, 2023 - journals.lww.com
Purpose: The summary presented herein covers recommendations on the early detection of
prostate cancer and provides a framework to facilitate clinical decision-making in the …